✦ LIBER ✦

Induction of cytotoxic T lymphocytes to murine mammary tumor cells with a Kd restricted immunogenic peptide

✍ Scribed by Wei-Zen Wei; Randall F. Gill; Richard F. Jones; Darcy Lichlyter; Jean-Pierre Abastado

Publisher: John Wiley and Sons
Year: 1996
Tongue: French
Weight: 555 KB
Volume: 66
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19960529)66:5<659::aid-ijc13>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A HER2/NEU-derived peptide, a Kd-restric

A HER2/NEU-derived peptide, a Kd-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes

✍ Yasushi Ikuta; Toshiharu Okugawa; Reiko Furugen; Yasuhiro Nagata; Yoshiyuki Taka 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 2 views

We have identified an H-2K(d)-binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2-specific murine cytotoxic T lymphocytes (CTL). Weekly vaccination of BALB/c mice by syngeneic dendritic cells pulsed with HER2p780 peptide, entirely common to murine and hum

A novel human HER2-derived peptide homol

A novel human HER2-derived peptide homologous to the mouse Kd-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals

✍ Toshiharu Okugawa; Yasushi Ikuta; Yoshiyuki Takahashi; Hidenori Obata; Koji Tani 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Induction of prostate tumor-specific CD8

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

✍ Peshwa, Madhusudan V.; Shi, Jia Dong; Ruegg, Curtis; Laus, Reiner; van Schooten, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## BACKGROUND. Most strategies in cancer immunotherapy are aimed at the induction of a strong cellular immune response against the tumor. Particularly, CD8 + T lymphocytes have been proven in multiple animal models to be critical for the eradication of solid tumors. METHODS. We used a population o

Coupling of antigen to cholera toxin for

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor

✍ Kristina Eriksson; Jia-Bin Sun; Inger Nordström; Margareta Fredriksson; Marianne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Identification of GP100-derived, melanom

Identification of GP100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells

✍ Ichiro Kawashima; Van Tsai; Scott Southwood; Kazutoh Takesako; Esteban Celis; Al 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 2 views

The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i

Treatment of colon and breast carcinoma

Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro

✍ Pierpaolo Correale; Angelo Aquino; Antonio Giuliani; Monia Pellegrini; Lucia Mic 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Cancer vaccines directed against tumor associate antigen (TAA) have produced encouraging results in preclinical models but not in cancer patients. A major limitation of this strategy is the relative degree of tolerance to these antigens and the low and heterogeneous tumor cell expressio